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ABSTRACT
Objectives: Transient ischaemic attack (TIA) is a
medical emergency requiring rapid access to effective,
organised, stroke prevention. There are about 90 000
TIAs per year in the UK. We assessed whether stroke-
prevention services in the UK meet Government
targets.
Design: Cross-sectional survey.
Setting: All UK clinical and imaging stroke-prevention
services.
Intervention: Electronic structured survey delivered
over the web with automatic recording of responses
into a database; reminders to non-respondents. The
survey sought information on clinic frequency, staff,
case-mix, details of brain and carotid artery imaging,
medical and surgical treatments.
Results: 114 stroke clinical and 146 imaging surveys
were completed (both response rates 45%).
Stroke-prevention services were available in most (97%)
centres but only 31% operated 7 days/week. Half of the
clinic referrals were TIA mimics, most patients (75%)
were prescribed secondary prevention prior to clinic
referral, and nurses performed the medical assessment
in 28% of centres. CT was the most common and
fastest first-line investigation; MR, used in 51% of
centres, mostly after CT, was delayed up to 2 weeks in
26%; 51% of centres omitted blood-sensitive (GRE/
T2*) MR sequences. Carotid imaging was with
ultrasound in 95% of centres and 59% performed
endarterectomy within 1 week of deciding to operate.
Conclusions: Stroke-prevention services are widely
available in the UK. Delays to MRI, its use in addition to
CT while omitting key sequences to diagnose
haemorrhage, limit the potential benefit of MRI in stroke
prevention, but inflate costs. Assessing TIA mimics
requires clinical neurology expertise yet nurses run 28%
of clinics. Further improvements are still required for
optimal stroke prevention.
BACKGROUND
Transient ischaemic attack (TIA) and minor
stroke are medical emergencies. In the UK,
there are 80 000–90 000 TIAs and minor
strokes every year.1 2 The beneﬁt of medical
or surgical treatment to prevent recurrent
stroke after TIA is greatest if given as early as
possible3–5; the beneﬁt falls rapidly with
increasing delay.6 7 Patients with TIA and
minor stroke need a rapid, comprehensive
assessment and active management to
reduce the short-term and long-term risks of
recurrent stroke. Establishing an accurate
diagnosis and delivering effective stroke pre-
vention is challenging and requires orga-
nised stroke services. National Health Service
(NHS) Improvement in England introduced
tariffs to encourage the establishment of
ARTICLE SUMMARY
Article focus
▪ Is the current provision of stroke-prevention clin-
ical services adequate to meet the volume of
work in the UK?
▪ Is access to brain and carotid imaging adequate
to meet the demand and is imaging being used
efficiently?
▪ Who is providing these services?
Key messages
▪ Most responding centres had some form of
rapid access stroke-prevention clinic.
▪ Front-line assessment was by nurses in nearly a
third of clinics, but about half of patients have a
transient ischaemic attack mimic which requires
medical expertise for diagnosis.
▪ There was an efficient use of CT of the brain and
carotid ultrasound imaging, but less good
access to MR brain imaging and this was often
used incorrectly or inefficiently.
Strengths and limitations of this study
▪ The survey covered the whole of the UK and
achieved a 45% response rate.
▪ Clinical and imaging service responses were
highly concurrent.
▪ Services may be much worse in areas that did
not respond.
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stroke-prevention services which meet the key perform-
ance criteria; there are supplementary tariffs for achiev-
ing optimum management of high risk TIA patients by
rapid triage of patients with ABCD2 score ≥4 including
use of MRI (additional amount payable £450 to £634
per patient in 2012, equivalent to $670–945 US).8 9 We
surveyed the UK clinical and imaging secondary stroke-
prevention services to determine their performance
against recent guidelines.10
METHODS
We devised two electronic survey questionnaires: one for
clinical stroke-prevention services and one for imaging
services using the online survey software ‘SurveyMonkey’
(http://www.surveymonkey.com). These were informed
by previous questionnaires sent to stroke services which
achieved high response rates.11–13 We used a ‘closed’,
‘structured’ response format. Both questionnaires pro-
vided information on the rationale and the purpose of
the study, including details of the research team, and
incorporated best research practice issues such as conﬁ-
dentiality and informed consent.
Following pilot testing, the agreed versions of the
survey questionnaires (available on request) contained
detailed questions addressing the current provision of
stroke-prevention services (56 questions) and imaging
services (47 questions) focusing on the volume of work,
capacity, professionals involved, type and timing of brain
and carotid imaging (within or outside normal ofﬁce
hours, for inpatients or outpatients) and carotid end-
arterectomy rates. We considered eligible participants to
be all clinical leads of the UK stroke services and radi-
ology departments.
We offered no incentives to participate in the surveys.
The responses were completely anonymous and the
completion was voluntary; hence, the approval of Ethics
Committees was not required. We sent letters of invita-
tion explaining the objectives and providing links to
access the questionnaires online in April 2011 by email
or post, via multiple routes, to all UK stroke clinical
leads and Radiology Directorates, including: stroke leads
of all 15 NHS Boards in Scotland through the Scottish
Stroke Care Audit; the 27 stroke networks (with three to
nine clinical sites within each network) through NHS
Improvement following contact with the Department of
Health; to Stroke Leads in Trust Hospitals through the
Royal College of Physicians Sentinel Stroke Audit data-
base (200 hospitals in 158 Trusts in England, Wales and
Northern Ireland); to Radiology Directorate Leads in
England through NHS Improvement and the Magnetic
Resonance National Evaluation Team database; all 12
Scottish Clinical Directors of Radiology through the
Diagnostic Imaging Clinical Network and to clinical and
imaging stroke services in Wales through the Stroke
Collaborative. The surveys went to 171 Acute Trusts, 129
Foundation Trusts, seven Welsh Trusts, hospitals in the
15 NHS Boards in Scotland and hospitals in Northern
Ireland. We estimated from the contact lists that there
were in total 253 Stroke Services sites and 342 Radiology
Departments to contact although there is no central list
of all this information in one place. Our questionnaire
included questions about stroke patients that were
assessed at the hospital generally as well as in speciﬁc
clinics, for example, in acute receiving units or general
medicine, with the intention of obtaining information
on all stroke-prevention pathways. Details of the surveys
and the online links were also disseminated through the
Royal College of Physicians website and advertised
through the NHS Improvement Stroke and Radiology
newsletters. Reminder messages were sent to non-
respondents in June 2011.
Data management and analysis
The results of both internet surveys were reported
according to the Checklist for Reporting Results of
Internet E-Surveys (CHERRIES) statement.14
Surveys results were generated using SurveyMonkey
software and entered into an Excel spreadsheet. We
expressed the clinical leads’ answers as proportions,
medians or means. Not all respondents answered all the
questions, therefore the percentages reported are of the
actual numbers of respondents. To calculate the
response rate, we divided the number of clinical leads to
whom we initially sent the invitation to participate by
the number of participants who actually completed the
online questionnaires. However, as both surveys were
also disseminated and advertised through professional
body websites and newsletters, it was not feasible to cal-
culate the exact number of all potential respondents
contacted. The surveys were completed anonymously,
and therefore it was not possible to associate services
with geographical location.
RESULTS
One hundred and fourteen Stroke Service surveys and
146 Imaging Service surveys were partially or fully com-
pleted, a response rate of 45% for each.
Stroke-prevention clinics
Among the 114 respondents, the mean catchment popu-
lation was 400 000 people (median 300 000); 97% indi-
cated that their hospital had a specialist stroke-
prevention clinic. The service was run at least once a
week in 99%; every weekday in 47% and every day in
31%. Most centres (86%, 88/102 respondents) saw
between one and ﬁve new patients per clinic. In half of
the clinics (51/102 respondents), the estimated propor-
tion of patients ultimately diagnosed as TIA/minor
stroke mimics was 41–60%; in 31% of centres, it was
between 60% and 79%. In only 16% of centres did def-
inite TIA/minor strokes make up the majority (61–
100%) of attendees (ﬁgure 1).
Thirty-ﬁve per cent of the TIA/minor stroke patients
were seen by the stroke-prevention clinic within 24 h,
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25% between 2 and 3 days and about 20% within 1 week
of their symptoms. Thirteen per cent of centres indi-
cated that patients considered as high risk according to
the ABCD2 risk prediction score were seen within 24 h
of referral and low-risk patients within 7 days.
Most stroke-prevention clinics were run by consultants
(stroke physicians; neurologists; geriatricians). However,
the main medical assessment/triaging was undertaken
by nurses in 28% of centres. The ﬁnal diagnosis was
established either with input from, or by a consultant in
71% of centres.
In most centres, most patients seen at the specialist
stroke-prevention service had already been prescribed
secondary prevention drugs (eg, aspirin; statins) for
their recent suspected TIA/minor stroke by their refer-
ring doctor (see online supplementary table S1).
Brain imaging of TIA/minor stroke
The stroke services survey showed that CT was routinely
used as the main brain imaging modality in 84% (98/
114 respondents) and that MRI was used in only 51% of
centres for stroke prevention. This concurred very
closely with the imaging services survey which showed
that CT was the main modality in most departments
(86%, 49/57 respondents). Details of access to CT and
MR are provided in online supplementary tables S2 and
S3. The stroke prevention as well as imaging surveys also
showed that most patients were having CT as the ﬁrst-
line test (ﬁgure 2A,B). The proportion of TIA/minor
stroke patients for whom a subsequent MRI was
requested after an initial CT varied considerably (range
0–60%; see online supplementary ﬁgure S1), the waiting
time for MR after CT being 1 month in about half of
centres (47%). The results of brain imaging were
returned to the stroke service on the day of scanning in
66% of centres; for 22%, however, it took more than
2 days. In most centres (76%), positive brain imaging
results (eg, haemorrhage) were provided to the stroke-
prevention clinic immediately.
The routine MR sequences used for TIA/minor stroke
were primarily focused on detecting ischaemia:
T1-weighted or T2-weighted, diffusion-weighted imaging
(DWI) and Fluid Attenuated Inversion Recovery
sequences. Fewer than half of the departments (49%)
performed sequences that are sensitive to haemorrhage
(eg, gradient echo, GRE/T2*; see online supplementary
ﬁgure S2). Some departments (18%) used only DWI
and T2-weighted sequences routinely, thus limiting the
chance of detecting either cerebral haemorrhage or
non-vascular brain lesions that mimic stroke/TIA.
Carotid artery imaging and endarterectomy
Carotid artery imaging most frequently took place the day
of the clinic (47%, 47/100 respondents). Doppler ultra-
sound (DUS) was the ﬁrst-line carotid/vertebral imaging in
most centres (95%). Most centres (80%) provided the
results of carotid artery imaging on the same day, and most
centres (86%; 85/99 respondents) provided important
positive results immediately. A repeat DUS (19%) or CTA
(60%) or contrast MRA (41% of centres) was used as con-
ﬁrmatory tests prior to referral for endarterectomy.
The time between the decision to perform a carotid
endarterectomy and the actual surgical procedure was
less than 1 week in 59% of centres and between 1 and
3 weeks in approximately 37% of centres (see online
supplementary ﬁgure S3). No stroke service performed
endarterectomy more than 6 months after the decision
to operate.
Workload volume and capacity
During 2010, on average of 4905 CT brain scans were
performed per radiology department (range 20–48 346;
median 2500), 18% were conducted out-of-hours but
with considerable variation. On average, 686 CT brain
scans were for patients with suspected TIA/minor stroke
(range 0–5000 scans; median 200 scans), that is, about
14% of the total workload. On average, 9% of these CT
scans were performed out-of-hours (range 0–60% scans;
median 2% scans).
During 2010, on average, 2888 brain MRI were per-
formed per radiology department (range 20–24 391
scans; median 1530 scans), only 3% of MR scans were
conducted out-of-hours (most performed no MR brain
imaging out-of-hours). On average, 258 MR brain scans
were conducted on patients suspected of TIA/minor
stroke (range 0–1200 scans; median 100 scans), that is,
about 9% of the total workload.
Forty-three per cent of the stroke-prevention centres
indicated that they had spare capacity to see further
patients. Responses varied as to what extra facilities were
required to expand the current stroke service (ﬁgure 3),
‘more consultants’ being the most frequent, but ‘more
carotid imaging’ was required in 53%. When ‘more brain
imaging’ was chosen, all respondents opted for more
MRI (38/38 respondents) rather than CT (14/38).
Figure 1 Proportion of patients attending the
stroke-prevention clinic who were ultimately diagnosed as
having transient ischaemic attack or minor stroke. In total, 102
of the 114 centres answered this question.
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DISCUSSION
These simultaneous surveys of stroke-prevention clinics
and imaging services indicate that the necessary compo-
nents of stroke-prevention services are widely available in
the UK, but their structure and organisation vary consid-
erably and an important proportion of practice remains
suboptimal (box 1). In most centres (78%), specialist
stroke-prevention services operate every weekday with an
average of ﬁve new patients attending each clinic, yet
only 60% of patients were seen within 1 week of their
event. Additionally, over half the case-load are patients
with a ﬁnal diagnosis of a non-TIA/minor stroke
Figure 3 Resources needed to
expand capacity in fully saturated
stroke-prevention services. In
total, 77/114 responded.
Participants were asked to
choose all suitable answers.
Figure 2 Proportion of patients
suspected of transient ischaemic
attack/minor stroke who had CT
or MRI as first-line brain imaging
investigation. (A) Imaging
services survey (55/146
responders). (B)
Stroke-prevention services survey
(101/114 responders).
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‘mimic’. Specialist medical knowledge is required for
accurate diagnosis and appropriate medical manage-
ment of this very heterogeneous case-mix, yet in a
quarter of clinics, the main assessment is by nurses.
The consistency between the clinical services’
responses and imaging departments’ responses to the
question about ﬁrst-line imaging method is striking
(ﬁgure 2A,B). CT as well as MR is widely available, but
access to CT is more rapid and more complete than for
MR, particularly outside normal ofﬁce hours and for
outpatients (see online supplementary tables S2 and
S3). MR was commonly performed in addition to and
after CT—possibly somewhat inappropriately since the
diagnostic yield from MR for ischaemic lesions on diffu-
sion imaging declines rapidly with time after the event.15
The survey did not include a question on why MR was
performed in addition to CT (or vice versa); therefore,
we are not able to say why this practice was so common.
Furthermore, in more than half the centres, the key MR
sequence required to identify haemorrhage accurately
(ie, GRE/T2* or equivalent) was omitted (see online
supplementary ﬁgure S2),16 increasing the risk that hae-
morrhages would be misdiagnosed as ischaemic events17
(one of the two main reasons for brain imaging in TIA/
minor stroke) leading to these patients receiving poten-
tially inappropriate antithrombotic or anticoagulant
treatment or even offered inappropriate carotid end-
arterectomy. Some centres that only use DWI and T2 are
also likely to miss some stroke/TIA mimics that could
otherwise be diagnosed with MR (the other of the two
main reasons for brain imaging in TIA/minor stroke).
Most patients had already been started on secondary
prevention by their general practitioners before they
reached the clinic (see online supplementary table S1),
further questioning the value of MR performed in
addition to CT, especially as the MR was frequently too
late to be of great diagnostic utility.
The surveys conﬁrmed that DUS is the main carotid
imaging for TIA (95%) not MRA or CTA, perhaps
reﬂecting that the potential for a ‘combined brain and
carotid’ examination (eg, CT+CTA or MR+MRA) is not
practical in most centres. In 59% of stroke services, end-
arterectomy was performed within 1 week of the deci-
sion to operate. The decreasing delay to surgery is
encouraging and is in line with guidelines and recent
audit reports,18 but the persistence of delays of up to a
month in nearly 40% of patients remains a concern.
The surveys were targeted to clinical leads of stroke-
prevention services and radiology departments.
Response rate for both surveys was 45% which we consid-
ered satisfactory for such a survey in view of the large
number of departments surveyed, the busy workload of
service leads and their many administrative tasks. The
response rates in three previous surveys about stroke ser-
vices were higher, but these took place among much
smaller catchment groups where many of the respon-
dents knew the surveyors personally and were highly
motivated about the topic of the survey.11–13 The present
survey went to a substantially larger number of sites
across the whole of the UK and inevitably could not
achieve the same personal touch. The strengths include
our use of several mechanisms to prevent sampling bias
and increase response rate. We used multiple routes to
access all stroke and imaging services clinical leads in
the UK and web-based questionnaires for the ease of
completion. We sent reminders to non-respondents. We
reported our ﬁndings according to the standard meth-
odology (ie, CHERRIES checklist). We provided web
and paper surveys to assist respondents. We based these
surveys on several previous surveys of stroke services that
achieved high response rates.11–13
There were also limitations. The survey was anonymous
and voluntary so we are not able to chart service distribu-
tion across the UK. We cannot exclude the possibility that
some centres submitted two surveys. To protect the ano-
nymity of the participants we also did not request full
demographic details, so were unable to compare respon-
dents with non-respondents. Our ﬁndings may, therefore,
not apply to all stroke-prevention services. Although both
internet surveys provided invaluable data to picture
current clinical practice, some data were not routinely
collected in all centres and respondents were only able to
estimate some answers. Not all respondents answered all
questions. Even though the 45% response rate for both
surveys can be considered satisfactory, we cannot be sure
to have captured the full range of performance with
respect to current stroke service provision.
There are no other current nation-wide data on clin-
ical services or imaging for stroke prevention in the UK
or from other countries. MR usage for stroke is rising
rapidly in many countries. For example, the use of MR
rose by 235% in 10 states in the USA from 1999 to
2008,19 making diagnostic imaging the single fastest
Box 1 Key findings
▪ Nurses provide the primary assessment and diagnosis in
nearly a third of clinics.
▪ A total of 50% of patients attending these clinics have transient
ischaemic attack (TIA)/minor stroke mimic.
▪ Most patients (75%) have already started secondary-prevention
treatment before attending the clinic.
▪ CT for TIA and minor stroke is widely available (94%) and is
the first-line test in the vast majority of centres, and routinely
used in 82%.
▪ MR is available for TIA and minor stroke patients in 88% of
centres but in about half of those it is after an initial CT scan.
▪ There are long delays to MRI.
▪ The key MR sequence needed to diagnose haemorrhage is omitted
in more than half of the centres, reducing the value of MR.
▪ Ultrasound is the primary carotid imaging test in 95% of
centres.
▪ There is limited capacity to undertake more imaging although
about 40% of stroke services indicated that they had the cap-
acity to see more patients; however, the main barrier to seeing
more patients was the limited availability of MR.
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growing component of hospital costs rising by 213%
from 1999 to 2008 in the USA.19 MR was used in add-
ition to CT in about half of the patients, a similar
pattern to that found in our survey. The use of several
imaging tests will increase delays and further impede
rapid access to imaging. The increase in use is occurring
despite a lack of evidence in a recent systematic review
that MR signiﬁcantly changed management, or any ran-
domised trials, case–control or cohort studies of imaging
strategies to justify its increased use.20
We suggest that use of expensive resources in TIA/
minor stroke, such as brain imaging, could be improved
by ensuring that patients only have either CT or MR but
not both. Where MR is used, then it should be used as
fast as possible (beyond a few days after the TIA/minor
stroke is unlikely to detect recent ischaemia and would
be a waste of time for that purpose) and diagnostic
sequences should include those appropriate to avoid
misdiagnosing haemorrhage or TIA/minor stroke
mimics; this is particularly critical if MR is used in
patients whose presentation is delayed beyond 7 days
when CT will not differentiate haemorrhage. Further
consideration should be given to whether the wide-
spread use of nurse triage is the most effective way of
dealing with complex TIA/minor stroke mimics which
generally require some considerable medical experience
to differentiate from true TIA/minor stroke.
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